Ovid Therapeutics Inc. Common Stock

OVIDNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
2.44 USD
↘ 0.01 (0.41%)AT CLOSE (11:59 AM EDT)
2.50
↗ 0.06 (2.25%)
POST MARKET (AS OF 06:46 PM EDT)
Post Market
AS OF 06:46 PM EDT
2.50
↗ 0.06 (2.25%)
🔴Market: CLOSED

Ovid Therapeutics Inc. Common Stock (OVID) trades at $2.43 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. OVID is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jul 17, 2026.

Open?$2.43
High?$2.53
Low?$2.37
Prev. Close?$2.45
Volume?1.1M
Avg. Volume?3.1M
VWAP?$2.46
Rel. Volume?0.34x
Bid / Ask
Bid?$2.08 × 100
Ask?$2.44 × 100
Spread?$0.36
Midpoint?$2.26
Valuation & Ratios
Market Cap?457.3M
Shares Out?186.6M
Float?97.7M
Float %?75.0%
P/E Ratio?N/A
P/B Ratio?2.31
EPS?-$0.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Rare Disease Therapeutics
Employees
23
Market Cap
457.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ovidrx.com
Listed
2017-05-05
Address
441 NINTH AVENUE, 14TH FLOOR
NEW YORK, NY 10001
Phone: 212-776-4381
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
21
Piotroski F-Score?0/9Weak
Altman Z-Score?8.03Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?22.52%Squeeze Risk
Short Interest?22.0M
Days to Cover?3.8
Free Float97.7M
Avg Daily Volume5.8M
Settlement Date2026-06-30
Financial Health
Current Ratio?10.17Strong
Quick Ratio?10.17Strong
Cash Ratio?5.97Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
68
2.31CHEAP▾
P/S?
Peers
100
S&P
3
64.21HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
51.00HIGH▾
Returns & Efficiency
ROE?
S&P
9
-12.2%WEAK▾
ROA?
S&P
3
-10.7%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$363.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist